Learn More
Apexbio Technology LLC WZ3146 1214265-56-1 50mg

Supplier: Apexbio Technology LLC A888150
WZ3146 (CAS 1214265-56-1) is an irreversible inhibitor targeting mutated epidermal growth factor receptor (EGFR) specifically the L858R and E746 A750del variants with an IC50 of 2 nM for both mutants In non-small cell lung cancer (NSCLC) cell lines WZ3146 suppresses EGFR phosphorylation including in those harboring the T790M resistance mutation Mass spectrometry analyses indicate covalent bond formation between WZ3146 and the EGFR kinase domain predominantly at Cys797 WZ3146 serves as a valuable tool for investigating mutant-selective EGFR inhibition and resistance mechanisms in NSCLC research models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.